Skip to content

Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05687669
Enrollment
170
Registered
2023-01-18
Start date
2023-01-12
Completion date
2023-06-12
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-eclampsia Aggravated, Pre-Eclampsia; Complicating Pregnancy

Brief summary

Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury (AKI). In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for this purpose. But it was accused in many cases as a cause for AKI without any other organ damage along with the severe preeclampsia disease. Some previous studies supported this assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative for an old drug with a high safety profile. In this research protocol the researchers will study comparative effect of glyceryl trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during their stay in obstetric ICU.

Interventions

DRUGGlyceryl trinitrate vs phentolamine for prophylaxis against renal impairment

Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Group(A): Glyceryl trinitrate (GTN) is labelled with Drug A on syringe pump. Group(B): Phentolamine is labelled with Drug B on syringe pump.

Intervention model description

Prospective study will be done in Assiut university hospital obstetric ICU, 2 groups will be examined and randomly assigned: group A using glyceryl trinitrate (GTN) to emergency control of blood pressure and group B using phentolamine infusion to control blood pressure. Each group consists of 85patients:

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Severe preeclampsia defined by presentation of 2 or more of the following criteria: 1. Blood pressure more than 160/100 2. Proteinuria 3. Pitting edema 4. With or without organ dysfunctions

Exclusion criteria

1. Patient relatives' refusal 2. Recent active internal hemorrhage 3. Chronic renal impairment or failure on dialysis for any other etiology

Design outcomes

Primary

MeasureTime frameDescription
kidney function tests96 hours after interventioncreatinine in micromoles per liter and urea in millimole per liter

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026